Βιογραφικό


ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ

ΠΕΡΙΕΧΟΜΕΝΑ




A/A   ΕΝΟΤΗΤΑ


1          ΕΙΣΑΓΩΓΗ


2          ΑΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ


3          ΑΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ ΠΟΥ ΤΟ ABSTRACT BOOK ΕΙΝΑΙ ΣΤΟ INDEX MEDICUS


4          ΑΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΣΥΝΕΔΡΙΑ


5          ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΕΡΓΑΣΙΕΣ ΔΗΜΟΣΙΕΥΜΕΝΕΣ ΣΕ ΔΙΕΘΝΗ ΚΑΙ ΕΛΛΗΝΙΚΑ ΠΕΡΙΟΔΙΚΑ


6          ΣΥΝΤΑΚΤΙΚΗ ΕΠΙΤΡΟΠΗ-ΚΡΙΤΗΣ ΠΕΡΙΟΔΙΚΩΝ


7          ΕΡΕΥΝΗΤΙΚΕΣ ΜΕΛΕΤΕΣ


8          ΔΙΑΚΡΙΣΕΙΣ


9          ΣΤΡΑΤΙΩΤΙΚΗ ΘΗΤΕΙΑ


10        ΞΕΝΕΣ ΓΛΩΣΣΕΣ 




“ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ”



Εμμανουήλ Σ. Καλλίστρατος,

MD, PhD, FESC  


                                                   Διδάκτωρ Πανεπιστημίου Αθηνών


Fellow of European Society of Cardiology

Hypertension Specialist of ESH

Member of European Association for Cardiovascular Prevention and Rehabilitation

(EACPR) and Heart Failure Association of the ESC (HFA).

Nuvleus Member of Hellenic Association of Hypertension


Διεύθυνση:                                          Θουκυδίδου 37 Καλαμάκι Αλιμος,
                                                            Τηλ:  210 9829911, +306944730467
                                                            Fax:  210-8991465
                                                            kallistrat1972@gmail.com



Οικογενειακή Κατάσταση:                  ¨Έγγαμος με δύο παιδιά



Υπηκοότητα:                                       Ελληνική
Ακαδημαϊκή Μόρφωση:                     .            Speaker training ESH 2012

§                     March 2009 ESH Advanced Course on Hypertension Courmayeur, Italy

§                     01/2003, Διδακτορική διατριβή με θέμα ¨ Η επίδραση της καρβεδιλόλης στα επίπεδα του εγκεφαλικού νατριουριτικου πεπτιδίου”

§                     02/1998 – 11/1998, Άδεια Εξασκήσεως Επαγγέλματος, Ιατρική Σχολή Πανεπιστημίου Μπρέσια, Ιταλία

§                     Διπλωματική Εργασία με θέμα “Θεραπεία Καρκίνου του στομάχου στον ηλικιωμένο”, ως μέρος επταετούς έρευνας από την Πανεπιστημιακή Χειρουργική Κλινική της Μπρέσιας

§                     09/1991 – 02/1998, Ιατρική Σχολή Πανεπιστημίου Μπρέσια, Ιταλία. Βαθμός Αποφοίτησης: 98/110


Επαγγελματική Προϋπηρεσία:            Σεπτέμβριος 2021 -σήμερα

Αναπληρωτής Διευθυντής Β Καρδιολογικής Κλινικής
Metropolitan Hospital 

                                                                       Αύγουστος 2017-Σεπτέμβριος 2021

Υπεύθυνος καρδιαγγειακής αποκατάστασης
Ασκληπιείο Βούλας  

                                                                       Σεπτέμβριος 2011-Σεπτέμβριος 2021

Υπέυθυνος ιατρείου υπέρτασης και καρδιαγγειακής προστασίας
Ασκληπιείο Βούλας  (Center of Excellence στην Υπέρταση από την Ευρωπαϊκή Εταιρία Υπέρτασης)

                                                                       Ιούλιος 2007- Σεπτέμβριος 2011
Νοσοκομείο Ασκληπιείο
Ειδικευόμενος Ιατρός Καρδιολογίας

Ιούνιος 2006 – Ιούλιος 2007
Επιστημονικός συνεργάτης Πανεπιστήμιου Αθηνών Ιατρικής

Μάρτιος 2004 – Δεκέμβριος 2005
Νοσοκομείο Μεταξά
Ειδικευόμενος Ιατρός Παθολογίας

Ιανουάριος 2003
Επιστημονικός συνεργάτης Ωνασσείου Καρδιοχειρουργικού Κέντρου

Μάιος 2002 – Ιανουάριος 2003
Ιατρικό Αθηνών, ΙΑΣΙΣ Πειραιά
Εφημερεύων Ιατρός

                                                                       Απρίλιος 2001 – Απρίλιος 2002
Περιφερειακό Ιατρείο Χατζή, Μεσσηνίας
Αγροτικός Ιατρός

                                                                       Ιανουάριος 2001 – Απρίλιος 2001
Εκπαίδευση, Γενικό Νομαρχιακό Νοσοκομείο Καλαμάτας



ΔΙΔΑΚΤΟΡΙΚΗ ΔΙΑΤΡΙΒΗ


Τίτλος: « Η επίδραση της χορήγησης β-αναστολέα (καρβεδιλόλης) στα επίπεδα του εγκεφαλικού νατριουρητικού προπεπτιδίου (NT pro BNP) στην καρδιακή ανεπάρκεια »


                        Πανεπιστήμιο Αθηνών 2008


                        Βαθμολόγηση : Άριστα


Η διατριβή περιλαμβάνει τις παρακάτω δημοσιεύσεις:

Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
Kallistratos MS et al. J Heart Lung Transplant. 2008 Nov;27(11):1251-6.

N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
Kallistratos MS et al. Angiology. 2008 Jun-Jul;59(3):323-8.

Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function.
Kallistratos MS et al. Hell J Cardiol. 2008 Jan-Feb;49(1):26-32.

N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS et al. J Heart Lung Transplant. 2007 May;26(5):516-21

No incremental clinical information of NT Pro BNP at peak exercise over resting levels in patients with impaired left ventricular function.
Kallistratos MS et al. Int J Cardiol. 2007 Oct 1;121(2):221-3


ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΕΡΓΑΣΙΕΣ ΔΗΜΟΣΙΕΥΜΕΝΕΣ ΣΕ ΔΙΕΘΝΗ ΚΑΙ ΕΛΛΗΝΙΚΑ ΠΕΡΙΟΔΙΚΑ



H index: 23

CITATIONS: 2393

1 The diagnostic approach and management of hypertension in the emergency department.

Manolis AJ, Kallistratos MS, Koutsaki M, Doumas M, Poulimenos LE, Parissis J, Polyzogopoulou E, Pittaras A, Muiesan ML, Mancia G.

Eur J Intern Med. 2024 Mar;121:17-24. doi: 10.1016/j.ejim.2023.11.028. Epub 2023 Dec 11.

PMID: 38087668 Review.

2 Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes.

Manolis A, Kallistratos M, Poulimenos L, Thomopoulos C.

Am J Med Sci. 2024 Mar;367(3):155-159. doi: 10.1016/j.amjms.2023.12.001. Epub 2023 Dec 9.

PMID: 38072070 Review.

3 Deep learning approach to unmask hidden salt effects in the era of artificial intelligence.

Manolis AJ, Kallistratos MS.

Eur Heart J. 2023 Nov 7;44(42):4458-4460. doi: 10.1093/eurheartj/ehad673.

PMID: 37862594 No abstract available.

4 Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Arterial Hypertension of the Hellenic Society of Cardiology.

5 Kallistratos M, Konstantinidis D, Dimitriadis K, Sanidas E, Katsi V, Androulakis E, Vlachopoulos C, Toutouzas K, Kanakakis J, Sideris S, Kafkas N, Mavrogianni AD, Papadopoulos CH, Stefanidis A, Patsourakos N, Kachrimanidis I, Papaioannou N, Tsioufis C, Kochiadakis G, Marketou M.

Hellenic J Cardiol. 2024 Jan-Feb;75:82-92. doi: 10.1016/j.hjc.2023.08.008. Epub 2023 Aug 23.

PMID: 37619947 Free article.

6 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, Azizi M, Benetos A, Borghi C, Hitij JB, Cifkova R, Coca A, Cornelissen V, Cruickshank JK, Cunha PG, Danser AHJ, Pinho RM, Delles C, Dominiczak AF, Dorobantu M, Doumas M, Fernández-Alfonso MS, Halimi JM, Járai Z, Jelaković B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van de Borne P, Wanner C, Weber T, Williams B, Zhang ZY, Kjeldsen SE.

J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.

PMID: 37345492

Egan (USA), Serap Erdine (Turkey), Claudio Ferri (Italy), Slavomira Filipova (Slovak Republic), Anthony Heagerty (UK), Michael Hecht Olsen (Denmark), Dagmara Hering (Poland), Sang Hyun Ihm (South Korea), Uday Jadhav (India), Manolis Kallistratos (Greece), Kazuomi Kario (Ja …

7 How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases.

Manolis AJ, Kallistratos MS, Camafort M, Coca A.

Eur J Intern Med. 2023 Mar;109:22-29. doi: 10.1016/j.ejim.2023.01.007. Epub 2023 Jan 9.

PMID: 36631307 Review.

8 Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis.

Manolis A, Kallistratos M, Poulimenos L, Zamfir T, Thomopoulos C.

Hellenic J Cardiol. 2023 May-Jun;71:26-32. doi: 10.1016/j.hjc.2022.12.002. Epub 2022 Dec 5.

PMID: 36481415 Free article.

9 Skeletal muscle alterations and exercise intolerance in heart failure with preserved ejection fraction patients: ultrasonography assessment of diaphragm and quadriceps.

Andriopoulou M, Dimaki N, Kallistratos MS, Chamodraka E, Jahaj E, Vassiliou AG, Giokas G, Kotanidou A, Manolis AJ, Piepoli MF, Filippatos G.

Eur J Heart Fail. 2022 Apr;24(4):729-731. doi: 10.1002/ejhf.2462. Epub 2022 Mar 9.

PMID: 35229401 Free article. No abstract available.

10 State of the art approach to managing angina and ischemia: tailoring treatment to the evidence.

Manolis AJ, Boden WE, Collins P, Dechend R, Kallistratos MS, Lopez Sendon J, Poulimenos LE, Ambrosio G, Rosano G.

Eur J Intern Med. 2021 Oct;92:40-47. doi: 10.1016/j.ejim.2021.08.003. Epub 2021 Aug 18.

PMID: 34419311 Review.

 

11 Opportunistic screening for hypertension in the general population in Greece: International Society of Hypertension May Measurement Month 2019.

Stergiou GS, Menti A, Doumas M, Gkaliagkousi E, Grassos C, Kalaitzidis RG, Kallistratos MS, Katsi V, Krokidis X, Makris T, Manios E, Manolis A, Marketou M, Papadakis JA, Papadopoulos D, Protogerou A, Chatzopoulos M, Sarafidis P, Tsioufis C, Zebekakis P.

Eur Heart J Suppl. 2021 May 20;23(Suppl B):B66-B69. doi: 10.1093/eurheartj/suab024. eCollection 2021 May.

12 Verapamil-sensitive idiopathic left ventricular tachycardia and concomitant atrioventricular nodal reentrant tachycardia.

Varvarousis D, Andrikopoulos G, Polytarchou K, Poulimenos L, Kallistratos M, Tsinivizov P, Triantafyllis A, Sikiotis A, Manolis A.

J Electrocardiol. 2021 Jul-Aug;67:7-10. doi: 10.1016/j.jelectrocard.2021.04.013. Epub 2021 Apr 21.

PMID: 33979720

13 Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts' survey.

Doumas M, Andreadis E, Andronoglou M, Davlouros P, Dimitriadis K, Gkaliagkousi E, Grassos H, Hatzitolios A, Iliakis P, Kalaitzidis R, Kallistratos E, Kasiakogias A, Konstantinidis D, Kotsis V, Makris T, Manolis A, Moulias A, Marketou M, Papadakis I, Papadopoulos D, Poulimenos L, Sanidas E, Sarafidis P, Savopoulos C, Stergiou G, Tatakis F, Thomopoulos K, Triantafyllidi H, Triantafyllou A, Vlachakos D, Zebekakis P, Ziakas A, Papademetriou V, Tsioufis C; Task Force of the Greek ESH Excellence centers.

Hellenic J Cardiol. 2021 Sep-Oct;62(5):355-358. doi: 10.1016/j.hjc.2021.04.003. Epub 2021 Apr 22.

PMID: 33895312 Free article.

14 Opportunistic screening for hypertension: what does it say about the true epidemiology?

Menti A, Kalpourtzi N, Gavana M, Vantarakis A, Voulgari PV, Hadjichristodoulou C, Gkaliagkousi E, Doumas M, Kalaitzidis RG, Kallistratos MS, Karakosta A, Katsi V, Krokidis X, Manios E, Marketou M, Ntineri A, Papadakis JA, Papadopoulos D, Sarafidis P, Trypsianis G, Chatzopoulos M, Chlouverakis G, Alamanos Y, Zebekakis P, Touloumi G, Stergiou GS.

J Hum Hypertens. 2022 Apr;36(4):364-369. doi: 10.1038/s41371-021-00532-5. Epub 2021 Apr 9.

PMID: 33837294

15 Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?

Manolis A, Kallistratos M, Doumas M.

Curr Pharm Des. 2021;27(23):2714-2721. doi: 10.2174/1381612827666210406142933.

PMID: 33823773 Review.

16 Combined aerobic/resistance/inspiratory muscle training as the 'optimum' exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial.

Laoutaris ID, Piotrowicz E, Kallistratos MS, Dritsas A, Dimaki N, Miliopoulos D, Andriopoulou M, Manolis AJ, Volterrani M, Piepoli MF, Coats AJS, Adamopoulos S; ARISTOS-HF trial (Aerobic, Resistance, InSpiratory Training OutcomeS in Heart Failure) Investigators.

Eur J Prev Cardiol. 2021 Dec 29;28(15):1626-1635. doi: 10.1093/eurjpc/zwaa091.

PMID: 33624071 Clinical Trial.

17 Mid-day sleep and blood pressure in patients with arterial hypertension. Author's reply.

Kallistratos MS, Poulimenos LE, Manolis AJ.

Eur J Intern Med. 2021 Mar;85:117. doi: 10.1016/j.ejim.2020.12.014. Epub 2021 Jan 5.

PMID: 33419663 No abstract available.

18 Treating hypertension with beta blockers: the European Sleep Apnea Database.

Manolis AJ, Poulimenos LE, Kallistratos MS.

J Hypertens. 2021 Feb 1;39(2):231-233. doi: 10.1097/HJH.0000000000002653.

PMID: 33394857 No abstract available.

19 The effectiveness of Ergon Instrument-Assisted Soft Tissue Mobilization, foam rolling, and athletic elastic taping in improving volleyball players' shoulder range of motion and throwing performance: a pilot study on elite athletes.

Maniatakis A, Mavraganis N, Kallistratos E, Mandalidis D, Mylonas K, Angelopoulos P, Xergia S, Tsepis E, Fousekis K.

J Phys Ther Sci. 2020 Oct;32(10):611-614. doi: 10.1589/jpts.32.611. Epub 2020 Oct 3.

PMID: 33132517 Free PMC article.

20 Hypertension guidelines: Managing the differences or the patients?

Manolis AJ, Poulimenos LE, Kallistratos MS.

Eur J Intern Med. 2020 Dec;82:16-17. doi: 10.1016/j.ejim.2020.10.013. Epub 2020 Oct 20.

PMID: 33092953 No abstract available.

21 Cardiac arrhythmias in arterial hypertension.

Varvarousis D, Kallistratos M, Poulimenos L, Triantafyllis A, Tsinivizov P, Giannakopoulos A, Kyfnidis K, Manolis A.

J Clin Hypertens (Greenwich). 2020 Aug;22(8):1371-1378. doi: 10.1111/jch.13989. Epub 2020 Aug 9.

PMID: 32772484 Free PMC article. Review.

22 [Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19 pandemic.

Giannitsi S, Tsinivizov P, Poulimenos LE, Kallistratos MS, Varvarousis D, Manolis AJ, Tsamakis K, Rizos E, Spandidos DA, Tsiptsios D, Triantafyllis AS.

Exp Ther Med. 2020 Sep;20(3):2812-2814. doi: 10.3892/etm.2020.8968. Epub 2020 Jul 7.

PMID: 32765776 Free PMC article.

23 The effect of Mid-Day Sleep on blood pressure levels in patients with arterial hypertension.

Kallistratos MS, Poulimenos LE, Tsinivizov P, Varvarousis D, Kouremenos N, Pittaras A, Triantafyllis AS, Manolis AJ.

Eur J Intern Med. 2020 Oct;80:86-90. doi: 10.1016/j.ejim.2020.05.030. Epub 2020 May 29.

PMID: 32482599

24 Recent advances in understanding and managing resistant/refractory hypertension.

Doumas M, Imprialos KP, Kallistratos MS, Manolis AJ.

F1000Res. 2020 Mar 9;9:F1000 Faculty Rev-169. doi: 10.12688/f1000research.21669.1. eCollection 2020.

PMID: 32201574 Free PMC article. Review.

25 Beta blockers, calcium channel blockers, and long-acting nitrates for patients with stable angina and low blood pressure levels: should this recommendation be reconsidered?

Kallistratos MS, Poulimenos LE, Manolis AJ.

Eur Heart J. 2020 Jan 14;41(3):479. doi: 10.1093/eurheartj/ehz900.

PMID: 31883335 No abstract available.

26 The ESC 2019 CCS guidelines: Have we left our patients and scientific evidence behind?

Manolis AJ, Kallistratos MS, Poulimenos LΕ, Ambrosio G, Dechend R, Lopez-Sendon J, Rosano G, Collins P.

Eur J Intern Med. 2020 Feb;72:5-8. doi: 10.1016/j.ejim.2019.12.012. Epub 2019 Dec 24.

PMID: 31879185 Review.

27 Evaluation, risk stratification and management of hypertensive patients in the perioperative period.

Koutsaki M, Patoulias D, Tsinivizov P, Doumas M, Kallistratos M, Thomopoulos C, Poulimenos L, Agnelli G, Mancia G, Manolis A.

Eur J Intern Med. 2019 Nov;69:1-7. doi: 10.1016/j.ejim.2019.09.012. Epub 2019 Oct 9.

PMID: 31606306 Review.

28 Hypertension and aortic stenosis: no strangers, not anymore!

Manolis AJ, Kallistratos MS, Poulimenos LE.

J Hypertens. 2019 Nov;37(11):2156-2158. doi: 10.1097/HJH.0000000000002226.

PMID: 31567755 No abstract available.

29 Ivabradine and metoprolol in fixed dose combination: When, why and how to use it.

Katsi V, Skalis G, Kallistratos MS, Tsioufis K, Makris T, Manolis AJ, Tousoulis D.

Pharmacol Res. 2019 Aug;146:104279. doi: 10.1016/j.phrs.2019.104279. Epub 2019 May 17.

PMID: 31108185 Review.

30 Microvascular Complications of Type 2 Diabetes Mellitus.

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K.

Curr Vasc Pharmacol. 2020;18(2):117-124. doi: 10.2174/1570161117666190502103733.

PMID: 31057114 Review.

31 Recent published hypertension guidelines: A critical approach.

Manolis AJ, Kallistratos MS.

Eur J Intern Med. 2019 May;63:1-2. doi: 10.1016/j.ejim.2019.04.005. Epub 2019 Apr 27.

PMID: 31036435 No abstract available.

32 Manolis AJ, Kallistratos MS, Poulimenos LE. Angina and hypertension. Eur Heart J Suppl. 2019 Apr;21(Suppl C):C15-C16. doi: 10.1093/eurheartj/suz041. Epub 2019 Apr 10. PMID: 30996701; PMCID: PMC6456883.

33 Koutsaki M, Thomopoulos C, Achimastos A, Kallistratos M, Batistaki C, Chatziagelaki E, Soulioti E, Poulimenos L, Koutsaki S, Mela A, Mancia G, Manolis AJ. Perioperative SBP changes during orthopedic surgery in the elderly: clinical implications. J Hypertens. 2019 Aug;37(8):1705-1713. doi: 10.1097/HJH.0000000000002085.

34 Kallistratos MS, Pittaras A, Theodoulidis I, Grassos C, Poulimenos LE, Manolis AJ. Adverse Effects of Mineralocorticoid Receptor Antagonist Administration. Curr Pharm Des. 2018;24(46):5537-5541. doi: 10.2174/1381612825666190222144359.

35 bTsioufis K, Douma S, Kallistratos MS, Manolis AJ. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension. Clin Drug Investig. 2019 Apr;39(4):385-393.

36 Faselis C, Imprialos K, Grassos H, Pittaras A, Kallistratos M, Manolis A. Is very low LDL-C harmful? Curr Pharm Des. 2018;24(31):3658-3664. doi: 10.2174/1381612824666181008110643.

37 Tsinivizov P, Poulimenos LE, Kontogiannis N, Kyfnidis K, Koulia K, Christopoulos G, Kallistratos MS, Skyrlas A, Manolis AJ. Novel balloon-assisted catheter ''unknotting'' technique. Hellenic J Cardiol. 2019 Mar-Apr;60(2):134-136.

38 Kallistratos MS, Poulimenos LE, Giannitsi S, Tsinivizov P, Manolis AJ. Trimetazidine in the Prevention of Tissue Ischemic Conditions. Angiology. 2019 Apr;70(4):291-298.

39 Lovic D, Pittaras A, Kallistratos M, Tsioufis C, Grassos C, Djordjevic D, Tasic I, Manolis A. Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits. Cardiovasc Hematol Disord Drug Targets. 2018;18(2):114-119.

40 Katsi V, Kallistratos MS, Kontoangelos K, Sakkas P, Souliotis K, Tsioufis C, Nihoyannopoulos P, Papadimitriou GN, Tousoulis D. Arterial Hypertension and Health-Related Quality of Life. Front Psychiatry. 2017 Dec 4;8:270.

Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacol Res. 2018 Feb;128:322-326.

41 The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?

Katsi V, Georgountzos G, Kallistratos MS, Zerdes I, Makris T, Manolis AJ, Nihoyannopoulos P, Tousoulis D.

Front Pharmacol. 2017 May 5;8:247. doi: 10.3389/fphar.2017.00247. eCollection 2017.

PMID: 28529486 Free PMC article. Review.

42 Pulse Wave Velocity: Retrospective Analysis in a Balkan Normotensive and Hypertensive Population: A Study of 9923 Patients.

Lovic D, Kallistratos MS, Poulimenos L, Skyrlas A, Stojanov V, Jakovljevic B, Zdravkovic M, Koracevic G, Chamodraka E, Kouremenos N, Pittaras A, Kokkinos P, Tsinivizov P, Manolis A.

Angiology. 2018 Jan;69(1):59-64. doi: 10.1177/0003319717709859. Epub 2017 May 17.

PMID: 28514871

43 Antianginal Efficacy of Ivabradine/Metoprolol Combination in Patients With Stable Angina.

Zarifis J, Kallistratos M, Katsivas A; investigators of the Prospective, Non-interventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population With Coronary Artery Disease.

Clin Cardiol. 2016 Dec;39(12):697-702. doi: 10.1002/clc.22585. Epub 2016 Nov 23.

44 Medical treatment of stable angina: A tailored therapeutic approach.

Manolis AJ, Poulimenos LE, Ambrosio G, Kallistratos MS, Lopez-Sendon J, Dechend R, Mancia G, Camm AJ.

Int J Cardiol. 2016 Oct 1;220:445-53. doi: 10.1016/j.ijcard.2016.06.150. Epub 2016 Jun 25.

45 Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study.

Vlachopoulos C, Grammatikou V, Kallistratos M, Karagiannis A.

Curr Med Res Opin. 2016 Sep;32(9):1605-10. doi: 10.1080/03007995.2016.1193481. Epub 2016 Jun 22.

PMID: 27209900

46 Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.

Zarifis J, Grammatikou V, Kallistratos M, Katsivas A.

Angiology. 2017 Jan;68(1):10-18.

47 Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study. Zarifis J, Grammatikou V, Kallistratos M, Katsivas A; Investigators of the Prospective, Noninterventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population With Coronary Artery Disease. Clin Cardiol. 2015 Dec;38(12):725-32.

48 Blood pressure reduction and control with fixed-dose combination perindopril/amlodipine: A Pan-Hellenic prospective observational study.

Manolis A, Grammatikou V, Kallistratos M, Zarifis J, Tsioufis K.

J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):930-5.

49 Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?

Kassimis G, Davlouros P, Patel N, De Maria G, Kallistratos MS, Kharbanda RK, Manolis AJ, Alexopoulos D, Banning AP.

Cardiovasc Drugs Ther. 2015 Oct;29(5):481-93

50 The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies.

Katsi V, Kallistratos MS, Pavlidis AN, Karpettas N, Skoumas I, Pavleros N, Manolis AJ, Pitsavos C, Tousoulis D, Stefanadis C, Kallikazaros I.

Rev Cardiovasc Med. 2015;16(1):9-19.

51 Recent advances in the management of resistant hypertension.

Manolis AJ, Kallistratos MS, Doumas M, Pagoni S, Poulimenos L.

F1000Prime Rep. 2015 Jan 5;7:03

52 Vasodilator β-blockers: a different class of antihypertensive agents?

Kallistratos MS, Poulimenos LE, Manolis AJ.

Future Cardiol. 2014 Nov;10(6):669-71

53 The association of Restless Legs Syndrome with hypertension and cardiovascular disease.

Katsi V, Katsimichas T, Kallistratos MS, Tsekoura D, Makris T, Manolis AJ, Tousoulis D, Stefanadis C, Kallikazaros I.

Med Sci Monit. 2014 Apr 21;20:654-9.

54 New oral anticoagulants and the risk for intracranial hemorrhage.

Kallistratos MS, Poulimenos LE, Manolis AJ.

JAMA Neurol. 2014 Mar;71(3):370-1

55 Cardiovascular repercussions of the pseudoexfoliation syndrome.

Katsi V, Pavlidis AN, Kallistratos MS, Fitsios A, Bratsas A, Tousoulis D, Stefanadis C, Manolis AJ, Kallikazaros I.

N Am J Med Sci. 2013 Aug;5(8):454-9

56 The unappreciated importance of blood pressure in recent and older atrial fibrillation trials.

Manolis A, Doumas M, Poulimenos L, Kallistratos M, Mancia G.

J Hypertens. 2013 Nov;31(11):2109-17;

57 Sympathetic overactivity in hypertension and cardiovascular disease.

Manolis AJ, Poulimenos LE, Kallistratos MS, Gavras I, Gavras H.

Curr Vasc Pharmacol. 2014 Jan;12(1):4-15

58 Blood pressure. The forgotten factor in previous and recent studies regarding anticoagulation in atrial fibrillation.

Kallistratos MS, Manolis AJ, Mancia G.

Int J Cardiol. 2013 Oct 9;168(4):4434-5

59 Aortic valve stenosis and arterial hypertension: a synopsis in 2013.

Katsi V, Marketou M, Kallistratos MS, Makris T, Manolis AJ, Tousoulis D, Stefanadis C, Vardas P, Kallikazaros I.

Curr Hypertens Rep. 2013 Aug;15(4):298-303

60 Diagnosis and risk stratification in acute pulmonary embolism: the role of echocardiography.

Pavlidis AN, Kallistratos MS, Karamasis GV, Tsoukas AS, Levantakis IP, Mauropoulos D, Manolis AJ.

Rev Cardiovasc Med. 2013;14(1):56-65.

61 Phentermine and topiramate extended-release for the obesity: new kids on the block.

Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I. Recent Pat Cardiovasc Drug Discov. 2013 Apr;8(1):35-41

62 Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study.

Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos DV, Dritsas A.

Int J Cardiol. 2013 Sep 1;167(5):1967-72

63 Recent clinical trials in atrial fibrillation in hypertensive patients.

Manolis AJ, Kallistratos MS, Poulimenos LE.

Curr Hypertens Rep. 2012 Aug;14(4):350-9

64 Electrocardiographic changes in a patient with pulmonary embolism and septic shock.

Pavlidis AN, Poulimenos LE, Giannakopoulos AK, Tsoukas A, Kallistratos MS, Manolis AJ.

Korean Circ J. 2011 Nov;41(11):692-3

65  Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.

Kallistratos MS, Pavlidis AN, Chamodraka ES, Varounis C, Dritsas A, Laoutaris ID, Manolis AJ, Cokkinos DV. Angiology. 2012 Oct;63(7):516-21

66 Late traumatic aortic dissection.

Kallistratos MS, Pavlidis AN, Tsoukas AS, Mauropoulos D, Levantakis IP, Hesketh G, Manolis AJ.

Am J Emerg Med. 2012 Sep;30(7):1328.e5-8.

67 Pulmonary embolism caused by cysto-atrial shunt fragment.

Pavlidis AN, Kallistratos MS, Paidakakos N, Manolis AJ.

Rev Esp Cardiol. 2011 Sep;64(9):838-9. doi:

68 Pacemaker extrusion in a severely demented patient. Device reimplantation via the femoral approach.  Pavlidis AN, Orfanidis Z, Giannakopoulos A, Poulimenos LE, Kallistratos MS, Mpampageorgakas P, Manolis AJ. Exp Clin Cardiol. 2011 Summer;16(2):e11-2.

23 Native aortic valve endocarditis caused by Brevibacterium epidermidis in an immunocompetent patient.  Manetos CM, Pavlidis AN, Kallistratos MS, Tsoukas AS, Chamodraka ES, Levantakis I, Manolis AJ. Am J Med Sci. 2011 Sep;342(3):257-8

69 Five-vessel aortic arch associated with a bicuspid aortic valve.  Pavlidis AN, Tsoukas A, Danias PG, Kallistratos MS, Levantakis I, Manolis AJ. J Cardiovasc Med (Hagerstown). 2012 Jul;13(7):460-1

70 Relapsed pulmonary sarcoma presenting as congestive heart failure.

Pavlidis AN, Tsoukas AS, Kallistratos MS, Hesketh G, Manolis AJ.

Neth Heart J. 2011 Dec;19(12):534-5.

71 Prognostic significance of blood pressure response to exercise in patients with systolic heart failure.  Kallistratos MS, Poulimenos LE, Pavlidis AN, Dritsas A, Laoutaris ID, Manolis AJ, Cokkinos DV. Heart Vessels. 2012 Jan;27(1):46-52

72 Diagnostic modalities of the most common forms of secondary hypertension.

Kallistratos MS, Giannakopoulos A, German V, Manolis AJ. Hellenic J Cardiol. 2010 Nov-Dec;51(6):518-29.

73 Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos DV, Dritsas A. Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study.   Int J Cardiol. 2012 May 31. [Epub ahead of print]

74 Laoutaris ID, Dritsas A, Adamopoulos S, Manginas A, Gouziouta A, Kallistratos MS, Koulopoulou M, Voudris V, Cokkinos DV, Sfirakis P. Benefits of physical training on exercise capacity, inspiratory muscle function,  and quality of life in patients with ventricular assist devices long-term postimplantation.  Eur J Cardiovasc Prev Rehabil. 2010 Jun 19. [Epub ahead of print]

75 Laoutaris ID, Vasiliadis IK, Dritsas A, Mavrogeni S, Kallistratos MS, Manginas A, Chaidaroglou A, Degiannis D, Panagiotakos DB, Cokkinos DV High plasma adiponectin is related to low functional capacity in patients with chronic heart failure      Int J Cardiol. 2009 Jan 26. [Epub ahead of print]

76 Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV    Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients   J Heart Lung Transplant. 2008 Nov;27(11):1251-6

77 Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV  N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.   Angiology. 2008 Jun-Jul;59(3):323-8.

78 Laoutaris ID, Dritsas A, Brown MD, Manginas A, Kallistratos MS, Chaidaroglou A, Degiannis D, Alivizatos PA, Cokkinos DV. Effects of inspiratory muscle training on autonomic activity, endothelial vasodilator function, and N-terminal pro-brain natriuretic peptide levels in chronic heart failure.  Eur J Cardiopulm Rehabil Prev. 2008 Mar-Apr;28(2):99-106

79Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV  Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function.  Hellenic J Cardiol. 2008 Jan-Feb;49(1):26-32.

80 Laoutaris ID, Dritsas A, Brown MD, Manginas A, Kallistratos MS, Degiannis D, Chaidaroglou A, Panagiotakos DB, Alivizatos PA, Cokkinos DV  Immune response to inspiratory muscle training in patients with chronic heart failure  Eur J Cardiovasc Prev Rehabil. 2007 Oct;14(5):679-85

81 C Kosmas1*, M S Kallistratos1, Ps Kopterides2, J Syrios2, E Skopelitis2, N Mylonakis1, A Karabelis1, and N Tsavaris2. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol. 2008 Jan;134(1):75-82.

82 Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV  N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.  J Heart Lung Transplant. 2007 May;26(5):516-21.

83 Tsakonas GP, Kallistratos MS, Balamoti EK, Gassiamis A, Zizi-Sermpetzoglou A, Mylonakis N, Karabelis A, Kosmas C. Rare and aggressive metastatic, axial multifocal local epithelioid sarcoma associated with paraneoplastic granulocytosis and hypoglycaemia.  Lancet Oncol. 2007 Jan;8(1):82-4.

84 Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV No incremental clinical information of NT Pro BNP at peak exercise over resting levels in patients with impaired left ventricular function.Int J Cardiol. 2007 Oct 1;121(2):221-3.

85 Laoutaris ID, Dritsas A, Brown MD, Manginas A, Kallistratos MS, Sfirakis P, Cokkinos DV, Alivizatos PA. Inspiratory muscle training in a patient with left ventricular assist device.                                              Hellenic J Cardiol. 2006 Jul-Aug;47(4):238-41.





AΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ

  1. ASSOCIATION OF MID-DAY NAPS OCCURRENCE AND DURATION WITH BLOOD PRESSURE LEVELS IN HYPERTENSIVE PATIENTS. A PROSPECTIVE OBSERVATIONAL STUDY. Kallistratos, M.; Poulimenos, L.; Karamanou, A.; Kouremenos, N.; Koukouzeli, A.; Zacharopoulou, I.; Vrakas, S.; Chamodraka, E.; Tsoukanas, K.; Kasimis, G.; Chiotelis, I.; Kontogiannis, N.; Kyfnidis, K.; Xanthopoulou, I.; Manolis, A.J. ESC congress London 2015  

  2.  RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS. Zacharopoulou, I.; Tsoukas, A.; Kallistratos, M.S.; Poulimenos, L.E.; Kouremenos, N.; Karamanou, A.; Chamodraka, E.; Vrakas, S.; Kontogianis, N.; Martineos, A.; Tsoukanas, K.; Pagoni, S.; Kyfnidis, K.; Manolis, A.J. ESH congress Milan 2015                                                      
  3. IN HOSPITAL ASSESSMENT OF ARTERIAL BLOOD PRESSURE IN PATIENTS UNDERGOING ORTHOPAEDIC SURGERY. OFFICE AND AMBULATORY BLOOD PRESSURE MEASUREMENTS .Koutsaki, M.; Soulioti, E.; Kallistratos, M.S.; Flampuraris, V.; Koutsoupaki, A.; Sklika, E.; Makris, A.; Moschou, A.; Kouremenos, A.; Koukouzeli, A.; Tsoukas, A.; Mela, A.; Manolis, A.J. ESH congress Milan 2015
                                                                                                                              
  4. TREATMENT AND CONTROL OF VARIOUS RISK FACTORS IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION    Kallistratos, M.S.; Poulimenos, L.E.; Karamanou, A.; Kouremenos, N.; Koukouzeli, A.; Kontogianis, N.; Tsoukanas, K.; Vergis, K.; Zacharopoulou, I.; Vrakas, S.; Chamodraka, E.; Siama, A.; Pagoni, S.; Kyfnidis, K.; Manolis, A.J. ESH congress Milan 2015                                                                                                                     
    FITNESS STATUS AND RISK FOR ATRIAL FIBRILLATION.
    Pittaras, A.; Faselis, C.; Doumas, M.; Manolis, A. J.; Grassos, H.; Kifnidis, K.; Kouremenos, N.; Papavasileiou, M.; Kallistratos, M.; Athanasiadis, I.; Kokkinos, P. ESH congress Milan 2015     
        
  5. EFFECTIVENESS, ADHERENCE AND TOLERABILITY OF PERINDOPRIL/AMLODIPINE FIXED DOSE COMBINATION, IN DAILY CLINICAL PRACTICE. RESULTS FROM THE EMERALD STUDY.
    Vlachopoulos, C.; Grammatikou, V.; Kallistratos, M.; Karagiannis, A. ESH congress Milan 2015       
                                                                                                                                                  
  6. Impairment of left atrial myocardial dynamics in patients with hypertension
    E.S. Chamodraka, M.S. Kallistratos, V. Lezos, I. Zacharopoulou, N. Kouremenos, K. Bacalacou, I. Chiotelis, A. Koukouzeli, G. Daskalaki, A.J. Manolis.  ESC congress 2013 Amsterdam    
                                                                                                                                                                                       
  7. The effect of isolated masked nocturnal hypertension on arterial stiffness
    E. Bakalakou, K. Kyfnidis, E. Kallistratos, A. Tsoukas, E. Hamondraka, I. Zacharopoulou, N. Kouremenos, I. Chiotelis, A. Koukouzeli, A. Manolis.  ESH congress Milan 2013     
                                                                                                                                          
  8. MORTALITY RISK IS ATTENUATED IN HYPERTENSIVE INDIVIDUALS WITH TYPE 2 DIABETES:
    Manolis, A. J.; Pittaras, A.; Doumas, M.; Kallistratos, M. S.; Kouremenos, N.; Faselis, C.; Nylen, E.; Kokkinos, J. P.; Kokkinos, P. ESH congress Milan 2011   

  9.  THE ROLE OF MULTIPLE RISK FACTORS FOR ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS:
    Zacharopoulou, I.; Bale, C.; Kallistratos, M. S.; Kouremenos, N.; Molos, I.; Zamfir, T.; Manetos, C. H.; Kalogiros, A.; Spanos, K.; Kyfnidis, K.; Manolis, A. J. ESH congress Milan 2011   
  10. Vasiliki Katsi, Georges Souretis, Ioannis Skiadas, Charalambos Vlachopoulos, Manolis S Kallistratos, Christodoulos Stefanadis, and Ioannis Kallikazaros
    Association between eye vasculature alterations and renal damage in essential hypertensives with metabolic syndrome. American Heart Association (AHA) Scientific Sessions April 1 - 5, 2011, New Orlean   
  11. Dennis V. Cokkinos, Ioannis D. Laoutaris, Athanassios Manginas, Stamatis Adamopoulos, Manolis S. Kallistratos, Constantinos Doulaptsis, Gregory Pavlides, and Athanasios Dritsas
    Benefits of combined aerobic/resistance/inspiratory muscle training in patients with chronic heart failure. The ideal exercise program for CHF?  American Heart Association (AHA) Scientific Sessions April 1 - 5, 2011,New Orleans                                                   
  12. I. Zacharopoulou, C. Bale , MS Kallistratos , CH. Antonakoudis , A.J. Manolis. Predictive model of different atrial fibrillation types applied in the clinical setting. 21st European Meeting on Hypertension and Cardiovascular Prevention June 17 - 20, 2011 
  13. I. Zacharopoulou, C. Bale, MS Kallistratos, K. Kyfnidis, A.J. Manolis. The role of multiple risk factors for atrial fibrillation in hypertensive patients.  21st European Meeting on Hypertension and Cardiovascular Prevention June 17 - 20, 2011                
  14. M.S Kallistratos, A Pavlidis , E Chamodraka, A Dritsas, ID Laoutaris, DV Cokkinos , AJ Manolis. Prognostic and predictive value of NT pro BNP at peak exercise over resting levels in Hypertensive patients with impaired left ventricular function. 21st European Meeting on Hypertension and Cardiovascular Prevention June 17 - 20, 2011
                     
  15. AJ Manolis, A Pittaras, M Doumas, MS Kallistratos, C Faselis, E Nylen, JP Kokkinos, P Kokkinos  Mortality risk is attenuated in Hypertensive Individuals with type 2 Diabetes. 21st European Meeting on Hypertension and Cardiovascular Prevention June 17 - 20, 2011
  16. M S Kallistratos, A Dritsas, I D Laoutaris, LE Poulimenos, A Pittaras, D V  Cokkinos, A Manolis. The prognostic value of blood pressure in cardiopulmonary exercise test.: A simple, cost effective and strong predictor of outcomes in patients with HF. 21st European Meeting on Hypertension and Cardiovascular Prevention June 17 - 20, 2011
  17. I D Laoutaris, S Adamopoulos, A Manginas, L Louca, MS Kallistratos, A Gkouziouta, V Vartela, A Dritsas      Comparison of functional status between patients with ventricular assist devices and patients after heart transplantation.    EuroPRevent 2011. 14 Apr 2011 - 16 Apr 2011 , Geneva - Switzerland
  18. I.D. Laoutaris, A. Manginas, S. Adamopoulos, M.S. Kallistratos, D.V. Cokkinos, G. Pavlides, A Dritsas. Combined aerobic/resistance/inspiratory muscle training in patients with chronic heart failure. The ideal exercise program from CHF? 5th International Meeting of The Onassis Cardiac Surgery Center  September 16–18, 2010 Athens, Greece

  19. I.D. Laoutaris, A. Dritsas, S. Adamopoulos, A. Manginas, A. Gouziouta, V. Vartela, M.S. Kallistratos, D. Chilidou, L. Louca, D.Zarkalis, G. Stavridis, P. Sfi rakis. Comparison of functional status between patients with mechanical circulatory support and patients after heart transplantation. 5th International Meeting of The Onassis Cardiac Surgery Center  September 16–18, 2010 Athens, Greece
  20.  M S Kallistratos, A Dritsas, ID Laoutaris, A Pittaras, LE Poulimenos, A J Manolis, D V Cokkinos. Blood pressure at peak exercise is a strong predictor of outcomes in patients with heart failure. European Society of Cardiology Congress August 2010 Stockholm
  21. M S Kallistratos, A Dritsas, ID Laoutaris, A Pittaras, LE Poulimenos, A J Manolis, D V Cokkinos. Low blood pressure is associated with worse outcome in patients with systolic heart failure. 20th European meeting on hypertension June 2010 Norway                                                                                                                                       
    1. M S Kallistratos, V Lezos, X Manetos, T Zamfir, X Koukosi, G Antonakoudis, A J Manolis. Metabolic syndrome is associated with increase risk of atrial fibrillation in hypertensive patients.  20th European meeting on hypertension June 2010 Norway

    2. M S Kallistratos, A Dritsas, ID Laoutaris, A Pittaras, LE Poulimenos, A J Manolis, D V Cokkinos. Revisiting blood pressure: A simple cost effective and strong predictor of outcomes in patients with HF. A prospective study. 20th European meeting on hypertension June 2010 Norway
    3. ID Laoutaris, A Manginas, S Adamopoulos, MS Kallistratos, DV Cokkinos, A Dritsas. Combined aerobic/resistance/inspiratory muscle training in patients with chronic    heart failure. The ideal exercise program forCHF?.  EuroPrevent Meeting May 201
    4. A. Pittaras, J. Myers, ES Nylen, JP Kokkinos, M Kallistratos, A. Giannakopoulos , H. Grassos, P. Narayan,A J Manolis, P.F. Kokkinos. Improved exercise capacity has a beneficial effect in long term mortality risk of prediabetics European Society of Cardiology Congress August 2009 Barcelona
    5. A. Pittaras, J. Myers, A.J. Manolis , M. Doumas, M. Kallistratos,A Giannakopoulos, C. Faselis, S. Singh, P.F. Kokkinos
      Improved exercise capacity status has a strong association with long term mortality risk in both young and older pre-hypertensive men
      European Society of Cardiology Congress August 2009 Barcelona
    6. I.D. Laoutaris, A. Dritsas, A. Manginas, S. Adamopoulos, M.S. Kallistratos, P. Sfirakis, D.V. Cokkinos,P.A. Alivizatos. Combined whole body endurance/inspiratory muscle training improves exercise capacity and pulmonary function in patients with ventricular assist devices. Europrevent May 2009 Stockholm
    7. A Pittaras , J. Myers, A.J. Manolis , M. Kallistratos, A Giannakopoulos, H. Grassos, C. Faselis , S. Singh , P. Narayan, P.F. Kokkinos.  Long term beneficial effect of improved exercise capacity in mortality risk in    high-risk hypertensive men. 19th European Meeting on Hypertension June 2009
    8. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos   Pulse pressure, a simple non invasive method for the prognosis of death in heart        failure patients. European Society of Cardiology Congress August  2008, Munich,     Germany
    9. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos Τhe prognostic value of the chronotropic response index in heart failure patients. European Society of Cardiology Congress August  2008, Munich,     Germany
    10. Ioannis Laoutaris, Athanasios Dritsas,  Athanassios Manginas, M S. Kallistratos, Maria Koulopoulou, S Adamopoulos, P Sfirakis,  Dennis V. Cokkinos and Peter A Alivizatos   Benefits of a combined whole body endurance/inspiratory muscle training program in patients with ventricular assist devices   European Society of Cardiology Congress August  2008, Munich

    11. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos. Incremental value of NT pro BNP over Left Ventricle Ejection Fraction and aerobic capacity for estimating the prognosis in Heart Failure patient.  XXVIII European Section Meeting of the International Society for Heart Research Athens, May 28 - May 31, 2008
    12. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos. Incremental value of NT pro BNP over Left Ventricle Ejection Fraction and aerobic capacity for estimating the prognosis in Heart Failure patient. EuroPrevent Meeting May 2008, Paris
    13. C Kosmas, MS Kallistratos, J Sarantonis, J Syrios, E Skopelitis, N Tsavaris. Cardiotoxicity of fluoropirimidines in different schedules of administration: a prospective study. 7th Congress of the Balkan Union of Oncology, 2008
    14. Ioannis Laoutaris, Athansios Dritsas, Athanassios Manginas, Manolis S. Kallistratos, Antigoni  Chaidaroglou, Dimitrios Degiannis, and Dennis V. Cokkinos.  Adiponectin versus NT-proBNP in predicting functional capacity of patients with heart failure. American Heart Association (AHA) Scientific Sessions Orlando, Florida, USA
    15. Ioannis Laoutaris, Athansios Dritsas, Margaret D Brown, Athanasios Manginas, M.S Kallistratos, Demosthenes B. Panagiotakos, P. A. Alivizatos and Dennis V. Cokkinos. Immune response to inspiratory muscle training in patients with chronic heart failure. European Society of Cardiology Congress Sept 2007, Vienna, Austria
    16. I D Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, D Degiannis, A Chaidaroglou, P A Alivizatos, D V Cokkinos.Relationship between plasma adiponectin, pro-inflammatory cytokines, N-terminal Pro BNP levels and functional status in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain
    17. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos.N-terminal prohormone natriuretic peptide as a marker for detecting low functional class patients and candidates for heart transplantation: linear correlation with exercise tolerance. EuroPrevent Meeting April 2007, Madrid, Spain
    18. ID Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, DB Panagiotakos,  P A Alivizatos, D V Cokkinos. Immune response to inspiratory muscle training in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain
    19. I D Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, D Degiannis, A Chaidaroglou, P A Alivizatos, D V Cokkinos. Relationship between plasma adiponectin, pro-inflammatory cytokines, N-terminal Pro BNP levels and functional status in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain
                                                                                                                                                    
    20. I D Laoutaris, I. K Vasiliadis, A Dritsas, S Mavrogeni, A Manginas, M S Kallistratos, A Chaidaroglou, D Degiannis, D V Cokkinos. Plasma adiponectin positively correlates with N-terminal Pro Brain Natriuretic peptide only in patients with severe chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain

    21. M.S. Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.NT Pro BNP as a marker for detecting low functional class patients and candidates for cardiac transplantation. Linear correlation with exercise tolerance. 4TH International meeting of the Onassis Cardiac Surgery Center

    22. M.S. Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos. Chronotropic response index (CRI) is associated with functional capacity and NT Pro BNP levels in HF. 4TH International meeting of the Onassis Cardiac Surgery Center
    23. Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S. Kallistratos, P. A. Alivizatos and D. V. Cokkinos.     Inspiratory muscle training impruves quolity of life, assesed by 3 different questionnaires and functional status of CHF patients. 4TH International meeting of the Onassis Cardiac Surgery Center
    24. I.Laoutaris, J.Vasiliadis, A.Dritsas, S. Mavrogeni, A.Manginas, M.S.Kallistratos, A.Chaidaroglou, D.Degiannis, D.V.Cokkinos. Plasma adiponectin positively correlates with N-Terminal Pro Brain natriuretic peptide only in patients with severe CHF. 4TH International meeting of the Onassis Cardiac Surgery Center
    25. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas,O.Ionescu, M.S. Kallistratos, P. A. Alivizatos and D. V. Cokkinos.   Maximal inspiratory pressure as a determinant of exercise capacity in patients with CHF. 4TH International meeting of the Onassis Cardiac Surgery Center
    26. Laoutaris, A. Dritsas, M.D. Brown, A. Manginas,M.S. Kallistratos, D.Degiannis, A.Chaidaroglou, P. A. Alivizatos and D. V. Cokkinos.Improvement in exercise capacity after inspiratory muscle training does not correspond to an immune response in chronic heart failure patients. 4TH International meeting of the Onassis Cardiac Surgery Center
    27. Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S. Kallistratos, A.Panagiotpoulou, S.Adamopoulos, P.Sfirakis, P. A. Alivizatos and D. V. Cokkinos.Influence of respiratory muscle training on exercise capacity in heart transplantation and chronic heart failure patients. 4TH International meeting of the Onassis Cardiac Surgery Center
    28. Laoutaris, A.Dritsas, M.D.Brown ,A.Manginas, M.S. Kallistratos D.Degiannis, A.Chaidaroglou,P. A. Alivizatos and D. V. Cokkinos.Relationship between plasma adiponectin, pro inflammatory cytokines, N T Pro BNP levels and functional capacity status in patients with CHF. 4TH International meeting of the Onassis Cardiac Surgery Center
    29. N.Τsavaris, N.Papadoniou, E.Scopelitis, M.S.Kallistratos.  Prognostic factors in patients with pancreatic adenocarcinoma. 11th  World Congress on advanced in oncology and 9th International Symposium on molecular Medicine
    30. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, O. Ionescou M. Kallistratos, P. A. Alivizatos and D. V. Cokkinos.   Maximal inspiratory pressure as a determinant of exercise capacity in patients with chronic heart failure. Heart Failure Congress 2006, June 2006, Helsinki, Finland
    31. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, O. Ionescou M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos
      Maximal inspiratory pressure as a determinant of exercise capacity in patients with chronic heart failure. EuroPrevent Meeting of the European Association of Cardiovascular Prevention and Rehabilitation, May 2006, Athens, Greece
    32. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M. S Kallistratos, M. Koulopoulou, P. A. Alivizatos and D. V. Cokkinos
      Respiratory muscle training improves exercise capacity in both heart transplant and chronic heart failure patients. EuroPrevent Meeting of the European Association of 
    33. Cardiovascular Prevention and Rehabilitation, May 2006, Athens, Greece
      M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos. No incremental value of NT pro BNP at peak exercise over resting levels in patients with impaired left ventricular function. World Congress of Cardiology, September 2006, Barcelona, Spain
    34. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, MS Kallistratos, P. A. Alivizatos and D. V. Cokkinos.    Improvement in life quality after inspiratory muscle training is associated with decreased dyspnea and an increase in 6-min walk test distance in chronic heart failure. World Congress of Cardiology, September 2006, Barcelona, Spain
    35. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, MS Kallistratos, M. Koulopoulou, P. A. Alivizatos and D. V. Cokkinos.Respiratory muscle training improves exercise capacity in both heart transplant and chronic heart failure patients World Congress of Cardiology, September 2006, Barcelona, Spain.
    36. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.    Improvement in Exercise Capacity After Inspiratory Muscle Training Is Associated With Reduced Dyspnea and Enhanced Limb Blood Flow in Chronic Heart Failure. American College of Cardiology Scientific Sessions (ACC) 2006, March 11-14, Atlanta, U.S.A.
    37. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.  Effects of inspiratory muscle training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. American Heart Scientific Sessions (AHA) 2005, Dallas, Texas, U.S.A
    38. I.Laoutaris, D. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.     Effects of inspiratory muscle training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. the European Society of Cardiology Annual Congress, September 2005, Stockholm, Sweden.
    39. I.Laoutaris, D. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.    Effects of Inspiratory Muscle Training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    40. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.     NT Pro BNP levels are strong predictors of functional capacity defined by cardiopulmonary exercise testing in heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    41. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos. Chronotropic response index (CRI) is associated with functional capacity and NT Pro BNPlevels in heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    42. Ioannis Laoutaris, Athansios Dritsas, Margaret D. Brown, Athanasios Manginas, M.S Kallistratos, P. A. Alivizatos and Dennis V. Cokkinos. Ιnspiratory muscle training using a test of incremental endurance alleviates dyspneaand improves functional capacity in chronic heart failure. Cardiovascular Prevention and Rehabilitation. Dublin 2004 Ireland.
    43. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos. NT Pro BNP levels are strong predictors of functional capacity defined by cardiopulmonary exercise testing in heart failure. Cardiovascular Prevention and Rehabilitation. Dublin 2004 Ireland. 

    ΑΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ ΠΟΥ ΤΟ ABSTRACT BOOK
     ΕΙΝΑΙ   ΣΤΟ INDEX MEDICUS


     


    1. Vasiliki Katsi, George Souretis, Ioannis Skiadas, Manolis S Kallistratos, Dimitris Tsiaxris, and Anastasios Koumoulidis. Reduce compliance with current guidelines for treating tobacco use among hypertensives
      J. Am. Coll. Cardiol., April 5, 2011; 57: E1190. 

    1. Vasiliki Katsi, Georges Souretis, Ioannis Skiadas, Charalambos Vlachopoulos, Manolis S Kallistratos, Christodoulos Stefanadis, and Ioannis Kallikazaros
      Association between eye vasculature alterations and renal damage in essential hypertensives with metabolic syndromeJ. Am. Coll. Cardiol., April 5, 2011; 57: E53

    1. Dennis V. Cokkinos, Ioannis D. Laoutaris, Athanassios Manginas, Stamatis Adamopoulos, Manolis S. Kallistratos, Constantinos Doulaptsis, Gregory Pavlides, and Athanasios Dritsas
      Benefits of combined aerobic/resistance/inspiratory muscle training in patients with chronic heart failure. The ideal exercise program for CHF?  J. Am. Coll. Cardiol., April 5, 2011; 57: E625

    1. I D Laoutaris, S Adamopoulos, A Manginas, L Louca, MS Kallistratos, A Gkouziouta, V Vartela, A Dritsas                                                               Comparison of functional status between patients with ventricular assist devices and patients after heart transplantation. Cardiovascular Prevention and Rehabilitation ( April 2011 ) 18 ( Supplement 1 ), S3Greece,

    1. Blood Pressure Response At Peak Exercise Is A Strong Predictor of Outcomes in Patients With Systolic Heart Failure: Pp.1.01
    Kallistratos, MS; Dritsas, A; Laoutaris, ID; Poulimenos, L; Pittaras, A; Manolis, AJ;   Cokkinos, DV  Journal of Hypertension. 28():e47, June 2010.

    1. Low Blood Pressure Is Associated With Worse Outcome in Patients With Systolic Heart Failure: Pp.3.121
    Kallistratos, MS; Dritsas, A; Laoutaris, ID; Pittaras, A; Poulimenos, L; Manolis, AJ; Cokkinos, DV
    Journal of Hypertension. 28():e84, June 2010.


    1. Kallistratos, MS; Lezos, V; Manetos, X; Zamfir, T; Koukosi, X; Antonakoudis, G; Zacharopoulou, I; Manolis, AJ
    Metabolic Syndrome Is Associated With Increased Risk of Atrial Fibrillation in      Hypertensive Patients:
    Journal of Hypertension:June 2010 - Volume 28 - Issue - p e58

    1. Revisiting Blood Pressure: A Simple, Cost Effective and Strong Predictor of Outcomes in Patients With Hf. A Prospective Study: Pp.36.494
    Kallistratos, MS; Dritsas, A; Laoutaris, ID; Poulimenos, LE; German, V; Pittaras, A; Cokkinos, DV; Manolis, AJ
    Journal of Hypertension. 28():e201, June 2010.

    1. Ioannis Laoutaris, Athanasios Dritsas,  Athanassios Manginas, M S. Kallistratos, Maria Koulopoulou, S Adamopoulos, P Sfirakis,  Dennis V. Cokkinos and Peter A Alivizatos
    Benefits of a combined whole body endurance/inspiratory muscle training program in patients with ventricular assist devices
    European Society of Cardiology Congress August  2008, Munich
    Eur Heart J 2008; Abstracts Supplement

    1. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos. Incremental value of NT pro BNP over Left Ventricle Ejection Fraction and aerobic capacity for estimating the prognosis in Heart Failure patient.  XXVIII European Section Meeting of the International Society for Heart Research Athens, May 28 - May 31, 2008
          Journal of Molecular and Cellular CardiologyVolume 44, Issue 4, April 2008,              Page 805

    1. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos. Incremental value of NT pro BNP over Left Ventricle Ejection Fraction and aerobic capacity for estimating the prognosis in Heart Failure patient. EuroPrevent Meeting May 2008, Paris
          Eur J Cardiov Prev Rehabil 2008; Αbstract Supplemen

    1. C Kosmas, MS Kallistratos, J Sarantonis, J Syrios, E Skopelitis, N Tsavaris. Cardiotoxicity of fluoropirimidines in different schedules of administration: a prospective study. 7th Congress of the Balkan Union of Oncology, 2008. BUON 2008, OP-178

    1. Ioannis Laoutaris, Athansios Dritsas, Athanassios Manginas, Manolis S. Kallistratos, Antigoni  Chaidaroglou, Dimitrios Degiannis, and Dennis V. Cokkinos.                                                                                                     Adiponectin versus NT-proBNP in predicting functional capacity of patients with heart failure. American Heart Association (AHA) Scientific Sessions Orlando, Florida, USA
          Circulation 2007; Abstracts Supplement

    1. Ioannis Laoutaris, Athansios Dritsas, Margaret D Brown, Athanasios Manginas, M.S Kallistratos, Demosthenes B. Panagiotakos, P. A. Alivizatos and Dennis V. Cokkinos.                                                                                                          Immune response to inspiratory muscle training in patients with chronic heart failure. European Society of Cardiology Congress Sept 2007, Vienna, Austria
                 Eur Heart J 2007; Abstracts Supplement

    1. I D Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, D Degiannis, A Chaidaroglou, P A Alivizatos, D V Cokkinos.                 Relationship between plasma adiponectin, pro-inflammatory cytokines, N-terminal Pro BNP levels and functional status in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain 
                 Eur Heart J 2007; Abstracts Supplement

    1. M.S   Kallistratos , Ioannis Laoutaris, Athansios Dritsas, DV Cokkinos.
    N-terminal prohormone natriuretic peptide as a marker for detecting low functional class patients and candidates for heart transplantation: linear correlation with exercise tolerance. EuroPrevent Meeting April 2007, Madrid, Spain 
    Eur J Cardiov Prev Rehabil 2007; Αbstract Supplement


    1. ID Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, DB Panagiotakos,  P A Alivizatos, D V Cokkinos.                                                                                                             Immune response to inspiratory muscle training in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain                                                                                                     Eur J Cardiov Prev Rehabil 2007; Αbstract Supplement

    1. I D Laoutaris, A Dritsas,  M D Brown*, A Manginas, M S Kallistratos, D Degiannis, A Chaidaroglou, P A Alivizatos, D V Cokkinos.                                                                               Relationship between plasma adiponectin, pro-inflammatory cytokines, N-terminal Pro BNP levels and functional status in patients with chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain 
    Eur J Cardiov Prev Rehabil 2007; Αbstract Supplement

    1. I D Laoutaris, I. K Vasiliadis, A Dritsas, S Mavrogeni, A Manginas, M S Kallistratos, A Chaidaroglou, D Degiannis, D V Cokkinos.                                                                                 Plasma adiponectin positively correlates with N-terminal Pro Brain Natriuretic peptide only in patients with severe chronic heart failure. EuroPrevent Meeting April 2007, Madrid, Spain 
                Eur J Cardiov Prev Rehabil 2007; Αbstract Supplement

    1. M.S. Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.                                                              NT Pro BNP as a marker for detecting low functional class patients and candidates for cardiac transplantation. Linear correlation with exercise tolerance. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-39

    1. M.S. Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.                                                    Chronotropic response index (CRI) is associated with functional capacity and NT Pro BNP levels in HF. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-45

    1. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S. Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                               Inspiratory muscle training impruves quolity of life, assesed by 3 different questionnaires and functional status of CHF patients. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-40

    1. I.Laoutaris, J.Vasiliadis, A.Dritsas, S. Mavrogeni, A.Manginas, M.S.Kallistratos, A.Chaidaroglou, D.Degiannis, D.V.Cokkinos.                                                                                                       Plasma adiponectin positively correlates with N-Terminal Pro Brain natriuretic peptide only in patients with severe CHF. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-41

    1. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas,O.Ionescu, M.S. Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                         Maximal inspiratory pressure as a determinant of exercise capacity in patients with CHF. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-43

    1. Laoutaris, A. Dritsas, M.D. Brown, A. Manginas,M.S. Kallistratos, D.Degiannis, A.Chaidaroglou, P. A. Alivizatos and D. V. Cokkinos.                                                                                          Improvement in exercise capacity after inspiratory muscle training does not correspond to an immune response in chronic heart failure patients. 4TH International meeting of the Onassis Cardiac Surgery Center
    Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-44

    1. Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S. Kallistratos, A.Panagiotpoulou, S.Adamopoulos, P.Sfirakis, P. A. Alivizatos and D. V. Cokkinos.                                                                                                       Influence of respiratory muscle training on exercise capacity in heart transplantation and chronic heart failure patients. 4TH International meeting of the Onassis Cardiac Surgery Center                                   Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-49

    1. Laoutaris, A.Dritsas, M.D.Brown ,A.Manginas, M.S. Kallistratos D.Degiannis, A.Chaidaroglou,P. A. Alivizatos and D. V. Cokkinos.                            Relationship between plasma adiponectin, pro inflammatory cytokines, N T Pro BNP levels and functional capacity status in patients with CHF. 4TH International meeting of the Onassis Cardiac Surgery Center                                                               Heart Surgery Forum; November-December 2006 Volume 9,Supplement;2: P-38

    1. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                                   Improvement in Exercise Capacity After Inspiratory Muscle Training Is Associated With Reduced Dyspnea and Enhanced Limb Blood Flow in Chronic Heart Failure. American College of Cardiology Scientific Sessions (ACC) 2006, March 11-14, Atlanta, U.S.A.                                                    Journal of American College of Cardiology (JACC) 2006; (Abstract Supplement)

    1. I.Laoutaris, A. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                                       Effects of inspiratory muscle training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. American Heart Scientific Sessions (AHA) 2005, Dallas, Texas, U.S.A                                                                                                                                          Circulation 2005; Vol 112;25: 3770 (Abstract Supplement)

    1. I.Laoutaris, D. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                                     Effects of inspiratory muscle training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. the European Society of Cardiology Annual Congress, September 2005, Stockholm, Sweden.                                                                                                    European Heart Journal 2005; Vol 26 (Abstract Supplement): 628.
    1. I.Laoutaris, D. Dritsas, M.D. Brown, A. Manginas, M.S Kallistratos, P. A. Alivizatos and D. V. Cokkinos.                                                                                                                                     Effects of Inspiratory Muscle Training on aerobic capacity, lung diffusion, autonomic and endothelial function in chronic heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    The Long-Term Approach in Cardiovascular Prevention and Rehabilitation. Abstract Book; ΟC 15
    SELECTED ABSRACT IN: European Journal of Cardiovascular Prevention and Rehabilitation, 2005;12: 287-288

    1. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.                                     NT Pro BNP levels are strong predictors of functional capacity defined by cardiopulmonary exercise testing in heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    The Long-Term Approach in Cardiovascular Prevention and Rehabilitation. Abstract Book; P 63
    SELECTED ABSRACT IN: European Journal of Cardiovascular Prevention and Rehabilitation, 2005;12: 287-288

    1. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos.                                                                     Chronotropic response index (CRI) is associated with functional capacity and NT Pro BNPlevels in heart failure. Cardiovascular Prevention and Rehabilitation. Spring Meeting, Leuven, April 7-10, 2005
    The Long-Term Approach in Cardiovascular Prevention and Rehabilitation. Abstract Book; SP 23
    1. Ioannis Laoutaris, Athansios Dritsas, Margaret D. Brown, Athanasios Manginas, M.S Kallistratos, P. A. Alivizatos and Dennis V. Cokkinos. Ιnspiratory muscle training using a test of incremental endurance alleviates dyspneaand improves functional capacity in chronic heart failure. Cardiovascular Prevention and Rehabilitation. Dublin 2004 Ireland.
    European Journal of Cardiovascular Prevention and Rehabilitation; 2004; Abstract Supplement; 11: O-93, P-77.
    Book of Abstracts; 5th International Conference on Nutrition and Fitness; June 2004- PRESENTED BY Professor D.V. Cokkinos

    1. M.S Kallistratos, A. Dritsas, I. Laoutaris, D. V. Cokkinos. NT Pro BNP levels are strong predictors of functional capacity defined by cardiopulmonary exercise testing in heart failure. Cardiovascular Prevention and Rehabilitation. Dublin 2004 Ireland.
    European Journal of Cardiovascular Prevention and Rehabilitation; 2004; Abstract Supplement; 11:P-77



    ΑΝΑΚΟΙΝΩΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΣΥΝΕΔΡΙΑ





    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Η προγνωστική αξία του δείκτη χρονότροπου απάντησης σε ασθενείς με καρδιακή ανεπάρκεια.
    10ο Πανελληνίου Συνεδρίου Καρδιακής Ανεπάρκειας 2009

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Μέτρηση της πίεσης σφυγμού (pulse pressure). Μία απλή, μη επεμβατική μέθοδος για την πρόγνωση των ασθενών με καρδιακή ανεπάρκεια
    10ο Πανελληνίου Συνεδρίου Καρδιακής Ανεπάρκειας 2009

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    NT pro BNP ως δείκτης για την ανίχνευση ασθενών με χαμηλή καρδιοαναπνευστική λειτουργική ικανότητα και υποψήφιων για μεταμόσχευση καρδιάς
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Η κλινική σημασία του προσδιορισμού του NT pro BNP κατα την άσκηση σε ασθενείς με καρδιακή ανεπάρκεια
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Η επίδραση της χορήγησης της καρβεδιλόλης στα επίπεδα του NT pro BNP  σε ασθενείς με καρδιακή ανεπάρκεια
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Ι Δ Λαουτάρης, Α Δρίτσας, M D Brown, Α Μαγγίνας, Μ.Σ Καλλίστρατος, O I Ionescu, Π Α Αλεβιζάτος, Δ Φ Κόκκινος.
    Η βελτίωση της ποιότητας ζωής μετά την άσκηση των αναπνευστικών μυών σχετίζεται με μειωμένη δύσπνοια και αύξηση της απόστασης βαδησης6- λεπτών ασθενών με ΧΚΑ
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Ι Δ Λαουτάρης, Α Δρίτσας, M D Brown, Α Μαγγίνας, Μ.Σ Καλλίστρατος, Μ Κουλοπούλου, Α Παναγιοτοποούλου, Π Α Αλεβιζάτος, Δ Φ Κόκκινος.
    Επίδραση της άσκησης των αναπνευστικών μυών στην αναπνευστική λειτουργία και ανοχή στην άσκηση ασθενών με μεταμόσχευση καρδιάς.
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Ι Δ Λαουτάρης, Α Δρίτσας, M D Brown, Α Μαγγίνας, Μ.Σ Καλλίστρατος, Δ Ντεγιάννης, Α Χαιδάρογλου, Π Α Αλεβιζάτος, Δ Φ Κόκκινος.
    Η βελτίωση της αερόβιας ικανότητας με την άσκηση των αναπνευστικών μυών σε ασθενείς με καρδιακή ανεπάρκεια
    27ο Πανελληνιο καρδιολογικο συνεδριο 2-4 Νοεμβριου 2006

    1. Μ Σ Καλλίστρατος, Λ Σάββα, Α Ευγενίδη, Χ Κοσμάς
    Το εγκεφαλικό νατριουριτικο πεπτίδιο (ΒΝΡ) ως δείκτης καρδιοτοξικότητας σε ασθενείς που υποβάλλονται σε χημειοθεραπεία
    13ο Πανελλήνιο συνέδριο κλινικής ογκολογίας

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Ο δείκτης της χρονότροπου απάντησης κατά την άσκηση σχετίζεται με την λειτουργικήικανότητα και τα επίπεδα NT PRO BNP στην καρδιακή ανεπάρκεια.
    Πανελληνιο καρδιολογικο συνεδριο 2005

    1. Μ.Σ. Καλλίστρατος, Ι.Δ.Λαουτάρης, Α.Δρίτσας, Δ.Φ.Κόκκινος
    Συσχέτιση των επιπέδων του εγκεφαλικού νατριουρητικού πεπτιδίου (NT Pro BNP)στο αίμα με την αερόβια ικανότητα στην καρδιακή ανεπάρκεια
    Πανελληνιο καρδιολογικο συνεδριο 2004





    ΣΥΝΤΑΚΤΙΚΗ ΕΠΙΤΡΟΠΗ – ΚΡΙΤΗΣ ΠΕΡΙΟΔΙΚΩΝ




    1. European Journal of Clinical Investigation

    1.  Journal of Clinical Cardiology

    1. Yonsei Medical Journal

    1. Anatolian Journal of Cardiology

    1. International Journal of Cardiology                                                                                                                                                                                                                        
    2. American Journal of Cardiology



    ΣΥΜΜΕΤΟΧΗ ΣΕ ΕΡΕΥΝΗΤΙΚΑ ΠΡΩΤΟΚΟΛΛΑ


    1. «Οι επιδράσεις της ιβαμπραδίνης στα καρδιαγγειακά συμβάντα σε ασθενείς με μέτρια έως βαρείας μορφής χρόνια καρδιακή ανεπάρκεια και συστολική δυσλειτουργία της αριστερής κοιλίας. Τριετής τυχαιοποιημένη διπλή-τυφλή ελεγχόμενη με εικονικό φάρμακο διεθνής πολυκεντρική μελέτη»(Shift study)

    1. «Τυχαιοποιημένη, διπλή-τυφλή μελέτη φάσης III ελέγχου της αποτελεσματικότητας και της ασφάλειας της ενδοφλέβιας σιδηρικής καρβοξυμαλτόζης (Ferinject) σε σύγκριση με εικονικό φάρμακο, σε ασθενείς με χρόνια καρδιακή ανεπάρκεια και σιδηροπενεία»(Vifor study)

    1. «Προοπτική, τυχαιοποιημένη, διπλή τυφλή, διπλή εικονική, παράλληλων ομάδων, πολυκεντρική, υποκινούμενη από σύμβαμα μελέτη μη κατωτερότητας για τη σύγκριση της αποτελεσματικότητας και της ασφάλειας του χορηγούμενου άπαξ ημερησίως από του στόματος Rivaroxaban (BAY 59-7939) με ρυθμισμένης δόσης από του στόματος βαρφαρίνη για την πρόληψη εγκεφαλικού επεισοδίου και συστηματικής εμβολής εκτός του κεντρικού νευρικού συστήματος σε συμμετέχοντες με μη βαλβιδική κολπική μαρμαρυγή»(Rocket study)

    1. Μία διπλή, πολυκεντρική, τυχαιοποιημένη πολυπαραγοντική ελεγχόμενη με εικονικό φάρμακο μελέτη παράλληλων ομάδων διάρκειας 8 εβδομάδων για την αξιολόγηση της αποτελεσματικότητας και ασφάλειας του aliskiren χορηγούμενο ως μονοθεραπεία καθώς και σε συνδυασμό με αμλοδιπίνη σε ασθενείς με ιδιοπαθή υπέρταση.


    ΔΙΑΚΡΙΣΕΙΣ


    1. C Kosmas, MS Kallistratos, J Sarantonis, J Syrios, E Skopelitis, N Tsavaris. Cardiotoxicity of fluoropirimidines in different schedules of administration: a prospective study.                                                                                                Best oral presentation 7th Congress of the Balkan Union of Oncology, 2008.

    1. I D Laoutaris, A Dritsas, M D Brown, A Manginas, M S Kallistratos, P A Alivizatos, D V Cokkinos                                                                               Inspiratory muscle training improves quality of life, assessed by 3 different questionnaires and functional status of chronic heart failure patients
    4th International Meeting of the Onassis Cardiac Surgery Center, 30 Nov-2 Dec 2006, Athens.
    1ο βραβείο καλύτερης επιστημονικής εργασίας

    1. Ioannis Laoutaris, Ioannis Vasiliadis, Athanasios Dritsas, Sofia Mavrogeni,  Athanassios Manginas, Manolis S. Kallistratos, Antigoni Chaidaroglou, Dimitrios Degiannis, D. Panagiotakos and Dennis V. Cokkinos
    High plasma adiponectin is related to low functional status in patients with chronic heart failure
    Πανελλήνιο Συνέδριο Καρδιακής Ανεπάρκειας 2008,Αθήνα
                2ο βραβείο καλύτερης επιστημονικής εργασίας

    1. Honorable Elite reviewer of AJC 2011
    1. Βραβείο Νικολάου Κεπετζή 2010
    2. Υποτροφία στην Αρτηριακή Υπέρταση απο την Ελληνική Εταιρεία Υπέρτασης 2012
    4. Βραβείο Alberto Ferrari - Πανευρωπαικό Συνέδριο Υπέρτασης 2014

    ΣΤΡΑΤΙΩΤΙΚΗ ΘΗΤΕΙΑ


    Μάρτιος 1999 – Σεπτέμβριος 2000, Υποδεκανέας, Ειδικότητα Ιατρός

    §     25/5/1999 – 25/02/2000, 505 Τάγμα Πεζοναυτών
    Ιατρός Τάγματος
    §     25/02/2000 – 25/09/2000, Ειδικό Τμήμα Αλεξιπτωτιστών
    Ιατρός Τμήματος


    ΓΝΩΣΗ ΞΕΝΩΝ ΓΛΩΣΣΩΝ


    §     Ελληνική 
    §     Ιταλική 
    §     Αγγλική 
    §     Γαλλική 

    Εγγραφή σε: Αναρτήσεις (Atom)

    Elsevier Reviewer

    Elsevier Reviewer